Tromethamine

Tromethamine

SCHEMBL3696191

NC(CO)(CO)CO.[Eu]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tromethamine SCHEMBL17484 1.00 MEN1 (1.00)
Tromethamine SCHEMBL975 1.00
Tromethamine SCHEMBL6427079 0.95
Tromethamine SCHEMBL2313359 0.95 MEN1 (0.91)
Tromethamine SCHEMBL4388579 0.95
Tromethamine SCHEMBL7126002 0.95
Tromethamine SCHEMBL9298764 0.95
Tromethamine SCHEMBL2263148 0.95 MEN1 (0.91)
Tromethamine SCHEMBL6063594 0.95
Tromethamine SCHEMBL2035496 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111406059-B Europium complexes 东曹株式会社 2023-04-18 CN disclosed
WO-2023277110-A1 LIGHT EMITTING MATERIAL AND USE OF SAME 国立大学法人千葉大学 2023-01-05 WO disclosed
US-20140206829-A1 ISOSELECTIVE POLYMERIZATION OF EPOXIDES CORNELL UNIVERSITY (US) 2014-07-24 US disclosed
EP-0885192-B8 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) 2012-05-16 EP disclosed
US-6686203-B2 Histologic visualization of cyanoacrylate embolization CALVO WILLIAM J (US) 2004-02-03 US disclosed
US-20020031443-A1 Histologic visualization of cyanoacrylate embolization CALVO WILLIAM J (US) 2002-03-14 US disclosed
EP-0885192-A1 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 1998-12-23 EP disclosed
WO-1997027177-A2 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-07-31 WO disclosed
EP-0604483-A1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE 4-HYDROXYTETRAHYDRO-2-PYRANONE DERIVATIVES ZENECA LIMITED (GB) 1994-07-06 EP disclosed
WO-1993006235-A1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE 4-HYDROXYTETRAHYDRO-2-PYRANONE DERIVATIVES ZENECA LIMITED (GB) 1993-04-01 WO disclosed
EP-0237080-B1 PROCESS FOR THE PREPARATION OF L(-)-CARNITINE CHLORIDE STARTING FROM 3,4-EPOXYBUTYRIC ESTERS ISTITUTO GUIDO DONEGANI S.p.A. (IT) 1992-06-03 EP disclosed
US-4888433-A CHIRAL HALOGENATED KETALS WHICH UNDERGO STEREOSELECTIVE REARRANGEMENT ZAMBON, S.P.A. (IT) 1989-12-19 US disclosed
EP-0299484-A1 Process for the preparation of intermediates for the synthesis of fosfomycin ZAMBON GROUP S.p.A. (IT) 1989-01-18 EP disclosed
EP-0158913-B1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-ARYLALKANOIC ACIDS AND INTERMEDIATES THEREOF ZAMBON S.p.A. (IT) 1988-07-20 EP disclosed
EP-0237080-A2 Process for the preparation of L(-)-carnitine chloride starting from 3,4-epoxybutyric esters ISTITUTO GUIDO DONEGANI S.p.A. (IT) 1987-09-16 EP disclosed